IE
ADIL

Israel Englander’s Adial Pharmaceuticals ADIL Stock Holding History

Israel Englander’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-63
Closed -$53K – 7013
2022
Q2 		$53K Buy
+63
New +$57K ﹤0.01% 6179
2022
Q1 		– Sell
-33
Closed -$56K – 6833
2021
Q4 		$56K Buy
33
+6
+22% +$11.8K ﹤0.01% 6446
2021
Q3 		$73K Buy
+27
New +$56.5K ﹤0.01% 6513
2019
Q2 		– Sell
-94
Closed -$201K – 3999
2019
Q1 		$201K Buy
+94
New +$280K ﹤0.01% 3733
2018
Q4 		– Sell
-27
Closed -$50K – 3702
2018
Q3 		$50K Buy
+27
New +$56K ﹤0.01% 3808

Other funds holding ADIL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
RWM
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's ADIL Position: Q3 2022 in Review

Israel Englander sold out of Adial Pharmaceuticals (ADIL) in Q3 2022, closing a stake of 63 shares — an estimated $53K sold.

Israel Englander first reported a position in ADIL in Q3 2018 and held it in 5 quarters. The position peaked at $201K in Q1 2019. 26 funds tracked by Wall St. Rank hold ADIL as of Q3 2022.

  • Israel Englander reported no remaining Adial Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Israel Englander sold 63 Adial Pharmaceuticals shares in Q3 2022, an estimated $53K.
  • Israel Englander first reported a position in Adial Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Israel Englander's Adial Pharmaceuticals position peaked at $201K in Q1 2019.
  • 26 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.